2023-2029 Global S-Amlodipine Industry Research & Trends Analysis Report
According to the research report, the global market for S-Amlodipine should grow from US$ 35600 million in 2022 to US$ 75320 million by 2029, with a CAGR of 11.3% for the period of 2023-2029.
Hypertension is a common cardiovascular disease affecting a large proportion of the global population. The increasing prevalence of hypertension worldwide is driving the demand for effective antihypertensive drugs such as S-amlodipine.
S AMLODIPINE belongs to a class of medicines called calcium channel blockers which are primarily taken to treat hypertension (high blood pressure) and angina (chest pain).
This report aims to provide a comprehensive study of the global market for S-Amlodipine. Report Highlights:
(1) Global S-Amlodipine market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global S-Amlodipine market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China S-Amlodipine market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global S-Amlodipine segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global S-Amlodipine segment by type and by application and regional segment by type and by application.
(6) Global major production regions of S-Amlodipine, capacity, production and trends.
(7) S-Amlodipine industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Amlodipine Besylate Tablets
Amlodipine Mesylate Tablets
Amlodipine Maleate Tablets
Market segment by application, can be divided into
Hypertension
Angina pectoris
Market segment by players, this report covers
Aristo Pharmaceuticals Pvt Ltd
Novartis
Pfizer
Lek
TEVA
Macleods Pharmaceuticals
Caraco Pharmaceutical
Sanis Health
Jamp Pharma
Accel Pharma
Jubilant Generics
Angita Pharma
Florida DOH Central Pharmacy
Chengdu Di'ao Pharmaceutical Group Co., Ltd.
Yangzijiang Pharmaceutical
1 Market Overview
1.1 S-Amlodipine Definition
1.2 Global S-Amlodipine Market Size and Forecast
1.2.1 By Revenue, Global S-Amlodipine Market Size, 2018-2029
1.2.2 By Sales Volume, Global S-Amlodipine Market Size, 2018-2029
1.2.3 Global S-Amlodipine Price Trend, 2018-2029
1.3 China S-Amlodipine Market Size and Forecast
1.3.1 By Revenue, China S-Amlodipine Market Size, 2018-2029
1.3.2 By Sales Volume, China S-Amlodipine Market Size, 2018-2029
1.3.3 China S-Amlodipine Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China S-Amlodipine Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China S-Amlodipine Share in Global Market, 2018-2029
1.4.3 S-Amlodipine Market Size: China VS Global, 2018-2029
1.5 S-Amlodipine Market Dynamics
1.5.1 S-Amlodipine Market Drivers
1.5.2 S-Amlodipine Market Restraints
1.5.3 S-Amlodipine Industry Trends
1.5.4 S-Amlodipine Industry Policy
2 Global Competitive Landscape by Company
2.1 Global S-Amlodipine Revenue by Company, 2018-2023
2.2 Global S-Amlodipine Sales Volume by Company, 2018-2023
2.3 Global S-Amlodipine Price by Company, 2018-2023
2.4 Global S-Amlodipine Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global S-Amlodipine Concentration Ratio
2.6 Global S-Amlodipine Mergers & Acquisitions, Expansion Plans
2.7 Global S-Amlodipine Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China S-Amlodipine Revenue by Company, 2018-2023
3.2 China S-Amlodipine Sales Volume by Company, 2018-2023
3.3 China S-Amlodipine S-Amlodipine Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China S-Amlodipine Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, S-Amlodipine Domestic VS Export
3.6 China Market, S-Amlodipine Import & Export
3.6.1 China Market, S-Amlodipine Import & Export, 2018-2029
3.6.2 China S-Amlodipine Import & Export Trends
3.6.3 Main Sources of China S-Amlodipine Import
3.6.4 Export Destination of China S-Amlodipine
4 S-Amlodipine Production by Region
4.1 Global S-Amlodipine Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of S-Amlodipine Manufacturers
4.3 Global Major Manufacturers, S-Amlodipine Capacity Expansion and Future Plans
4.4 Global S-Amlodipine Capacity by Region
4.5 Global S-Amlodipine Production by Region
4.5.1 Global S-Amlodipine Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global S-Amlodipine Production by Region, 2018-2023
4.5.3 Global S-Amlodipine Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 S-Amlodipine Industry Chain
5.2 S-Amlodipine Upstream Analysis
5.2.1 S-Amlodipine Core Raw Materials
5.2.2 Main Manufacturers of S-Amlodipine Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 S-Amlodipine Production Mode
5.6 S-Amlodipine Procurement Model
5.7 S-Amlodipine Industry Sales Model and Sales Channels
5.7.1 S-Amlodipine Sales Model
5.7.2 S-Amlodipine Typical Distributors
6 Sights by Type
6.1 S-Amlodipine Classification
6.1.1 Amlodipine Besylate Tablets
6.1.2 Amlodipine Mesylate Tablets
6.1.3 Amlodipine Maleate Tablets
6.2 By Type, Global S-Amlodipine Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global S-Amlodipine Revenue, 2018-2029
6.4 By Type, Global S-Amlodipine Sales Volume, 2018-2029
6.5 By Type, Global S-Amlodipine Price, 2018-2029
7 Sights by Application
7.1 S-Amlodipine Segment by Application
7.1.1 Hypertension
7.1.2 Angina pectoris
7.2 By Application, Global S-Amlodipine Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global S-Amlodipine Revenue, 2018-2029
7.4 By Application, Global S-Amlodipine Sales Volume, 2018-2029
7.5 By Application, Global S-Amlodipine Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global S-Amlodipine Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global S-Amlodipine Revenue, 2018-2029
8.3 By Region, Global S-Amlodipine Sales Volume, 2018-2029
8.4 North America
8.4.1 North America S-Amlodipine Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America S-Amlodipine Market Size Market Share
8.5 Europe
8.5.1 Europe S-Amlodipine Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe S-Amlodipine Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific S-Amlodipine Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific S-Amlodipine Market Size Market Share
8.7 South America
8.7.1 South America S-Amlodipine Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America S-Amlodipine Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global S-Amlodipine Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global S-Amlodipine Revenue, 2018-2029
9.3 By Country, Global S-Amlodipine Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. S-Amlodipine Market Size, 2018-2029
9.4.2 By Company, U.S. S-Amlodipine Sales Volume Market Share, 2022
9.4.3 By Type, U.S. S-Amlodipine Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. S-Amlodipine Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe S-Amlodipine Market Size, 2018-2029
9.5.2 By Company, Europe S-Amlodipine Sales Volume Market Share, 2022
9.5.3 By Type, Europe S-Amlodipine Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe S-Amlodipine Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China S-Amlodipine Market Size, 2018-2029
9.6.2 By Company, China S-Amlodipine Sales Volume Market Share, 2022
9.6.3 By Type, China S-Amlodipine Market Size, Share, 2022 VS 2029
9.6.4 By Application, China S-Amlodipine Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan S-Amlodipine Market Size, 2018-2029
9.7.2 By Company, Japan S-Amlodipine Sales Volume Market Share, 2022
9.7.3 By Type, Japan S-Amlodipine Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan S-Amlodipine Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea S-Amlodipine Market Size, 2018-2029
9.8.2 By Company, South Korea S-Amlodipine Sales Volume Market Share, 2022
9.8.3 By Type, South Korea S-Amlodipine Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea S-Amlodipine Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia S-Amlodipine Market Size, 2018-2029
9.9.2 By Company, Southeast Asia S-Amlodipine Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia S-Amlodipine Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia S-Amlodipine Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India S-Amlodipine Market Size, 2018-2029
9.10.2 By Company, India S-Amlodipine Sales Volume Market Share, 2022
9.10.3 By Type, India S-Amlodipine Market Size, Share, 2022 VS 2029
9.10.4 By Application, India S-Amlodipine Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia S-Amlodipine Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia S-Amlodipine Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia S-Amlodipine Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia S-Amlodipine Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Aristo Pharmaceuticals Pvt Ltd
10.1.1 Aristo Pharmaceuticals Pvt Ltd Company Information, Head Office, Market Area and Industry Position
10.1.2 Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Models, Specifications and Application
10.1.3 Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Aristo Pharmaceuticals Pvt Ltd Company Profile and Main Business
10.1.5 Aristo Pharmaceuticals Pvt Ltd Recent Developments
10.2 Novartis
10.2.1 Novartis Company Information, Head Office, Market Area and Industry Position
10.2.2 Novartis S-Amlodipine Models, Specifications and Application
10.2.3 Novartis S-Amlodipine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Novartis Company Profile and Main Business
10.2.5 Novartis Recent Developments
10.3 Pfizer
10.3.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.3.2 Pfizer S-Amlodipine Models, Specifications and Application
10.3.3 Pfizer S-Amlodipine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Pfizer Company Profile and Main Business
10.3.5 Pfizer Recent Developments
10.4 Lek
10.4.1 Lek Company Information, Head Office, Market Area and Industry Position
10.4.2 Lek S-Amlodipine Models, Specifications and Application
10.4.3 Lek S-Amlodipine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Lek Company Profile and Main Business
10.4.5 Lek Recent Developments
10.5 TEVA
10.5.1 TEVA Company Information, Head Office, Market Area and Industry Position
10.5.2 TEVA S-Amlodipine Models, Specifications and Application
10.5.3 TEVA S-Amlodipine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 TEVA Company Profile and Main Business
10.5.5 TEVA Recent Developments
10.6 Macleods Pharmaceuticals
10.6.1 Macleods Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.6.2 Macleods Pharmaceuticals S-Amlodipine Models, Specifications and Application
10.6.3 Macleods Pharmaceuticals S-Amlodipine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Macleods Pharmaceuticals Company Profile and Main Business
10.6.5 Macleods Pharmaceuticals Recent Developments
10.7 Caraco Pharmaceutical
10.7.1 Caraco Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.7.2 Caraco Pharmaceutical S-Amlodipine Models, Specifications and Application
10.7.3 Caraco Pharmaceutical S-Amlodipine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Caraco Pharmaceutical Company Profile and Main Business
10.7.5 Caraco Pharmaceutical Recent Developments
10.8 Sanis Health
10.8.1 Sanis Health Company Information, Head Office, Market Area and Industry Position
10.8.2 Sanis Health S-Amlodipine Models, Specifications and Application
10.8.3 Sanis Health S-Amlodipine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Sanis Health Company Profile and Main Business
10.8.5 Sanis Health Recent Developments
10.9 Jamp Pharma
10.9.1 Jamp Pharma Company Information, Head Office, Market Area and Industry Position
10.9.2 Jamp Pharma S-Amlodipine Models, Specifications and Application
10.9.3 Jamp Pharma S-Amlodipine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Jamp Pharma Company Profile and Main Business
10.9.5 Jamp Pharma Recent Developments
10.10 Accel Pharma
10.10.1 Accel Pharma Company Information, Head Office, Market Area and Industry Position
10.10.2 Accel Pharma S-Amlodipine Models, Specifications and Application
10.10.3 Accel Pharma S-Amlodipine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Accel Pharma Company Profile and Main Business
10.10.5 Accel Pharma Recent Developments
10.11 Jubilant Generics
10.11.1 Jubilant Generics Company Information, Head Office, Market Area and Industry Position
10.11.2 Jubilant Generics S-Amlodipine Models, Specifications and Application
10.11.3 Jubilant Generics S-Amlodipine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Jubilant Generics Company Profile and Main Business
10.11.5 Jubilant Generics Recent Developments
10.12 Angita Pharma
10.12.1 Angita Pharma Company Information, Head Office, Market Area and Industry Position
10.12.2 Angita Pharma S-Amlodipine Models, Specifications and Application
10.12.3 Angita Pharma S-Amlodipine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Angita Pharma Company Profile and Main Business
10.12.5 Angita Pharma Recent Developments
10.13 Florida DOH Central Pharmacy
10.13.1 Florida DOH Central Pharmacy Company Information, Head Office, Market Area and Industry Position
10.13.2 Florida DOH Central Pharmacy S-Amlodipine Models, Specifications and Application
10.13.3 Florida DOH Central Pharmacy S-Amlodipine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Florida DOH Central Pharmacy Company Profile and Main Business
10.13.5 Florida DOH Central Pharmacy Recent Developments
10.14 Chengdu Di'ao Pharmaceutical Group Co., Ltd.
10.14.1 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Company Information, Head Office, Market Area and Industry Position
10.14.2 Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Models, Specifications and Application
10.14.3 Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Company Profile and Main Business
10.14.5 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Recent Developments
10.15 Yangzijiang Pharmaceutical
10.15.1 Yangzijiang Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.15.2 Yangzijiang Pharmaceutical S-Amlodipine Models, Specifications and Application
10.15.3 Yangzijiang Pharmaceutical S-Amlodipine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Yangzijiang Pharmaceutical Company Profile and Main Business
10.15.5 Yangzijiang Pharmaceutical Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. S-Amlodipine Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. S-Amlodipine Market Restraints
Table 3. S-Amlodipine Market Trends
Table 4. S-Amlodipine Industry Policy
Table 5. Global S-Amlodipine Revenue by Company, 2018-2023, US$ million
Table 6. Global S-Amlodipine Revenue Market Share by Company, 2018-2023
Table 7. Global S-Amlodipine Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global S-Amlodipine Sales Volume Market Share by Company, 2018-2023
Table 9. Global S-Amlodipine Price by Company, 2018-2023, (US$/Unit)
Table 10. Global S-Amlodipine Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global S-Amlodipine Mergers & Acquisitions, Expansion Plans
Table 12. Global S-Amlodipine Manufacturers Product Type
Table 13. China S-Amlodipine Revenue by Company, 2018-2023, US$ million
Table 14. China S-Amlodipine Revenue Market Share by Company, 2018-2023
Table 15. China S-Amlodipine Sales Volume by Company, 2018-2023, (K Units)
Table 16. China S-Amlodipine Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, S-Amlodipine Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China S-Amlodipine Import & Export Trends
Table 19. Main Sources of China S-Amlodipine Import
Table 20. Export Destination of China S-Amlodipine
Table 21. Global Headquarters and Manufacturing Base of S-Amlodipine Manufacturers
Table 22. Global Major Manufacturers, S-Amlodipine Capacity Expansion and Future Plans
Table 23. Global S-Amlodipine Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global S-Amlodipine Production by Region, 2018-2023, (K Units)
Table 25. Global S-Amlodipine Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of S-Amlodipine Upstream (Raw Materials)
Table 27. Global S-Amlodipine Typical Customers
Table 28. S-Amlodipine Typical Distributors
Table 29. By Type, Global S-Amlodipine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global S-Amlodipine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global S-Amlodipine Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global S-Amlodipine Revenue, 2018-2029, US$ Million
Table 33. By Region, Global S-Amlodipine Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global S-Amlodipine Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global S-Amlodipine Revenue, 2018-2029, US$ Million
Table 36. By Country, Global S-Amlodipine Revenue Market Share, 2018-2029
Table 37. By Country, Global S-Amlodipine Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global S-Amlodipine Sales Volume Market Share, 2018-2029
Table 39. Aristo Pharmaceuticals Pvt Ltd Company Information, Head Office, Market Area and Industry Position
Table 40. Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Models, Specifications and Application
Table 41. Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Aristo Pharmaceuticals Pvt Ltd Company Profile and Main Business
Table 43. Aristo Pharmaceuticals Pvt Ltd Recent Developments
Table 44. Novartis Company Information, Head Office, Market Area and Industry Position
Table 45. Novartis S-Amlodipine Models, Specifications and Application
Table 46. Novartis S-Amlodipine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Novartis Company Profile and Main Business
Table 48. Novartis Recent Developments
Table 49. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 50. Pfizer S-Amlodipine Models, Specifications and Application
Table 51. Pfizer S-Amlodipine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Pfizer Company Profile and Main Business
Table 53. Pfizer Recent Developments
Table 54. Lek Company Information, Head Office, Market Area and Industry Position
Table 55. Lek S-Amlodipine Models, Specifications and Application
Table 56. Lek S-Amlodipine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Lek Company Profile and Main Business
Table 58. Lek Recent Developments
Table 59. TEVA Company Information, Head Office, Market Area and Industry Position
Table 60. TEVA S-Amlodipine Models, Specifications and Application
Table 61. TEVA S-Amlodipine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. TEVA Company Profile and Main Business
Table 63. TEVA Recent Developments
Table 64. Macleods Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 65. Macleods Pharmaceuticals S-Amlodipine Models, Specifications and Application
Table 66. Macleods Pharmaceuticals S-Amlodipine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Macleods Pharmaceuticals Company Profile and Main Business
Table 68. Macleods Pharmaceuticals Recent Developments
Table 69. Caraco Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 70. Caraco Pharmaceutical S-Amlodipine Models, Specifications and Application
Table 71. Caraco Pharmaceutical S-Amlodipine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Caraco Pharmaceutical Company Profile and Main Business
Table 73. Caraco Pharmaceutical Recent Developments
Table 74. Sanis Health Company Information, Head Office, Market Area and Industry Position
Table 75. Sanis Health S-Amlodipine Models, Specifications and Application
Table 76. Sanis Health S-Amlodipine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Sanis Health Company Profile and Main Business
Table 78. Sanis Health Recent Developments
Table 79. Jamp Pharma Company Information, Head Office, Market Area and Industry Position
Table 80. Jamp Pharma S-Amlodipine Models, Specifications and Application
Table 81. Jamp Pharma S-Amlodipine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Jamp Pharma Company Profile and Main Business
Table 83. Jamp Pharma Recent Developments
Table 84. Accel Pharma Company Information, Head Office, Market Area and Industry Position
Table 85. Accel Pharma S-Amlodipine Models, Specifications and Application
Table 86. Accel Pharma S-Amlodipine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Accel Pharma Company Profile and Main Business
Table 88. Accel Pharma Recent Developments
Table 89. Jubilant Generics Company Information, Head Office, Market Area and Industry Position
Table 90. Jubilant Generics S-Amlodipine Models, Specifications and Application
Table 91. Jubilant Generics S-Amlodipine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Jubilant Generics Company Profile and Main Business
Table 93. Jubilant Generics Recent Developments
Table 94. Angita Pharma Company Information, Head Office, Market Area and Industry Position
Table 95. Angita Pharma S-Amlodipine Models, Specifications and Application
Table 96. Angita Pharma S-Amlodipine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Angita Pharma Company Profile and Main Business
Table 98. Angita Pharma Recent Developments
Table 99. Florida DOH Central Pharmacy Company Information, Head Office, Market Area and Industry Position
Table 100. Florida DOH Central Pharmacy S-Amlodipine Models, Specifications and Application
Table 101. Florida DOH Central Pharmacy S-Amlodipine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Florida DOH Central Pharmacy Company Profile and Main Business
Table 103. Florida DOH Central Pharmacy Recent Developments
Table 104. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Company Information, Head Office, Market Area and Industry Position
Table 105. Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Models, Specifications and Application
Table 106. Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Company Profile and Main Business
Table 108. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Recent Developments
Table 109. Yangzijiang Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 110. Yangzijiang Pharmaceutical S-Amlodipine Models, Specifications and Application
Table 111. Yangzijiang Pharmaceutical S-Amlodipine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Yangzijiang Pharmaceutical Company Profile and Main Business
Table 113. Yangzijiang Pharmaceutical Recent Developments
List of Figure
Figure 1. S-Amlodipine Picture
Figure 2. By Revenue, Global S-Amlodipine Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global S-Amlodipine Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global S-Amlodipine Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China S-Amlodipine Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China S-Amlodipine Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China S-Amlodipine Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China S-Amlodipine Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China S-Amlodipine Share of Global Market, 2018-2029
Figure 10. Global S-Amlodipine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global S-Amlodipine Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China S-Amlodipine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China S-Amlodipine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China S-Amlodipine Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of S-Amlodipine Domestic VS Export, 2022
Figure 16. Global S-Amlodipine Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global S-Amlodipine Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global S-Amlodipine Production Market Share & Forecast by Region, 2018-2029
Figure 19. S-Amlodipine Industry Chain
Figure 20. S-Amlodipine Procurement Model
Figure 21. S-Amlodipine Sales Model
Figure 22. S-Amlodipine Sales Channels, Direct Sales and Distribution
Figure 23. Amlodipine Besylate Tablets
Figure 24. Amlodipine Mesylate Tablets
Figure 25. Amlodipine Maleate Tablets
Figure 26. By Type, Global S-Amlodipine Revenue, 2018-2029, US$ Million
Figure 27. By Type, Global S-Amlodipine Revenue Market Share, 2018-2029
Figure 28. By Type, Global S-Amlodipine Sales Volume, 2018-2029, (K Units)
Figure 29. By Type, Global S-Amlodipine Sales Volume Market Share, 2018-2029
Figure 30. By Type, Global S-Amlodipine Price, 2018-2029, (US$/Unit)
Figure 31. Hypertension
Figure 32. Angina pectoris
Figure 33. By Application, Global S-Amlodipine Revenue, 2018-2029, US$ Million
Figure 34. By Application, Global S-Amlodipine Revenue Market Share, 2018-2029
Figure 35. By Application, Global S-Amlodipine Sales Volume, 2018-2029, (K Units)
Figure 36. By Application, Global S-Amlodipine Sales Volume Market Share, 2018-2029
Figure 37. By Application, Global S-Amlodipine Price, 2018-2029, (US$/Unit)
Figure 38. By Region, Global S-Amlodipine Revenue Market Share, 2018-2029
Figure 39. By Region, Global S-Amlodipine Sales Volume Market Share, 2018-2029
Figure 40. North America S-Amlodipine Revenue & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, North America S-Amlodipine Revenue Market Share, 2022
Figure 42. Europe S-Amlodipine Revenue & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, Europe S-Amlodipine Revenue Market Share, 2022
Figure 44. Asia Pacific S-Amlodipine Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country/Region, Asia Pacific S-Amlodipine Revenue Market Share, 2022
Figure 46. South America S-Amlodipine Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country, South America S-Amlodipine Revenue Market Share, 2022
Figure 48. Middle East & Africa S-Amlodipine Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. U.S. S-Amlodipine Sales Volume, 2018-2029, (K Units)
Figure 50. By Company, U.S. S-Amlodipine Market Share, 2022
Figure 51. By Type, U.S. S-Amlodipine Sales Volume Market Share, 2022 VS 2029
Figure 52. By Application, U.S. S-Amlodipine Sales Volume Market Share, 2022 VS 2029
Figure 53. Europe S-Amlodipine Sales Volume, 2018-2029, (K Units)
Figure 54. By Company, Europe S-Amlodipine Market Share, 2022
Figure 55. By Type, Europe S-Amlodipine Sales Volume Market Share, 2022 VS 2029
Figure 56. By Application, Europe S-Amlodipine Sales Volume Market Share, 2022 VS 2029
Figure 57. China S-Amlodipine Sales Volume, 2018-2029, (K Units)
Figure 58. By Company, China S-Amlodipine Market Share, 2022
Figure 59. By Type, China S-Amlodipine Sales Volume Market Share, 2022 VS 2029
Figure 60. By Application, China S-Amlodipine Sales Volume Market Share, 2022 VS 2029
Figure 61. Japan S-Amlodipine Sales Volume, 2018-2029, (K Units)
Figure 62. By Company, Japan S-Amlodipine Market Share, 2022
Figure 63. By Type, Japan S-Amlodipine Sales Volume Market Share, 2022 VS 2029
Figure 64. By Application, Japan S-Amlodipine Sales Volume Market Share, 2022 VS 2029
Figure 65. South Korea S-Amlodipine Sales Volume, 2018-2029, (K Units)
Figure 66. By Company, South Korea S-Amlodipine Market Share, 2022
Figure 67. By Type, South Korea S-Amlodipine Sales Volume Market Share, 2022 VS 2029
Figure 68. By Application, South Korea S-Amlodipine Sales Volume Market Share, 2022 VS 2029
Figure 69. Southeast Asia S-Amlodipine Sales Volume, 2018-2029, (K Units)
Figure 70. By Company, Southeast Asia S-Amlodipine Market Share, 2022
Figure 71. By Type, Southeast Asia S-Amlodipine Sales Volume Market Share, 2022 VS 2029
Figure 72. By Application, Southeast Asia S-Amlodipine Sales Volume Market Share, 2022 VS 2029
Figure 73. India S-Amlodipine Sales Volume, 2018-2029, (K Units)
Figure 74. By Company, India S-Amlodipine Market Share, 2022
Figure 75. By Type, India S-Amlodipine Sales Volume Market Share, 2022 VS 2029
Figure 76. By Application, India S-Amlodipine Sales Volume Market Share, 2022 VS 2029
Figure 77. Middle East & Asia S-Amlodipine Sales Volume, 2018-2029, (K Units)
Figure 78. By Company, Middle East & Asia S-Amlodipine Market Share, 2022
Figure 79. By Type, Middle East & Asia S-Amlodipine Sales Volume Market Share, 2022 VS 2029
Figure 80. By Application, Middle East & Asia S-Amlodipine Sales Volume Market Share, 2022 VS 2029
Figure 81. Research Methodology
Figure 82. Breakdown of Primary Interviews
Figure 83. Bottom-up Approaches
Figure 84. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|